Tag: Europe
-
Biotech, A.I. Companies Model Animal Studies/Clinical Trials
A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.
-
Trial Advances of Dual-Action Cancer Immunotherapy
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study.
-
Companies Partner on Fast Production of Biologics in Plants
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities.
-
Digital Biomarkers Shown to Highlight Parkinson’s Disease
Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions.
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.
-
Crispr Therapy Shown to Reduce Harmful Gut Microbes
A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects.
-
AI-Designed Cancer Vaccine Shown to Act Against Melanoma
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors.
-
Pharma Company Gains Precise Gene Edits in $2B Biotech Deal
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders.
-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.